Refreshing results…
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Download from doi.orgAccelerating drug target inhibitor discovery with a deep generative foundation model
Download from doi.orgGeneration of SARS-CoV-2 escape mutations by monoclonal antibody therapy
Download from doi.orgRapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
Download from doi.orgA delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Download from doi.orgAntigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
Download from doi.orgAntibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
UploadPotent cross-reactive antibodies following Omicron breakthrough in vaccinees
UploadSARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
UploadSite-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
UploadAuthor Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Download from www.nature.comAssembly intermediates of orthoreovirus captured in the cell
Download from www.nature.comStructural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
UploadNeutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Download from www.nature.comGlutathione facilitates enterovirus assembly by binding at a druggable pocket
Download from doi.orgAtomic structure of the Epstein-Barr virus portal
Download from www.nature.comMissing publications? Search for publications with a matching author name.